Dubai Derma 2018 Concluded on a High Note
Mar 21, 2018

440 million dirhams worth business deals signed during the 3-day conference and exhibition

Dubai – United Arab Emirates, 21 March 2018: The 18th edition of Dubai World Dermatology and Laser Conference and Exhibition – Dubai Derma, held under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of the Dubai Health Authority, DHA, concluded today, after 3 days of highly successful discussions at the Dubai International Convention and Exhibition Centre, attracting over 15,000 visitors and participants and featuring highly specialized discussions on a number of key themes and topics related to skincare and latest treatment methodologies.

On the sidelines of the conference and exhibition, the scientific committee announced today the recommendations for the 18th edition of Dubai Derma. Dr. Ibrahim Galadari, Chairman of the Dubai Derma Conference and Professor of Dermatology at the UAE University announced the following recommendations of the Dubai Derma Conference 2018:

Recommendations of Dubai Derma Conference and Exhibition 2018:

• Increase the provision of supervisory staff to medical facilities working in plastic/cosmetic surgery and ensure that the scientific requirements for practicing the profession in this field are obtained for both doctors or technicians.

• The need to emphasize tougher restrictions over the use of cosmetics, especially laser, Botox and fillers, to avoid medical errors that may occur upon misuse.

• Emphasize the support of physicians, especially trainees and those registered in medical training programs – such as the Arab Board – and other specialized programs in the Arab World and direct these courses to increase the efficiency of physicians in their specialties to obtain the recognized certificates afterwards.

• Emphasize the need to organize workshops for physicians, especially workshops in which physicians acquire certain skills in the field of dermatology, plastic surgery and laser intervention.

• Emphasize the need to exchange medical experiences and ethics, especially in the area of skin beautification.

• Emphasize the need to apply what has been discussed in Dubai Derma 2018 through inviting the heads of international associations such as the American Academy of Dermatology, Asian Academy of Dermatology and Venerology, European Academy of Dermatology and Venerology and other associations to increase cooperation and exchange of experiences for the benefit of doctor and patient.

Eng. Anas Al Madani, Vice Chairman and Group CEO of INDEX Holding said, “Dubai Derma witnessed one more successful edition this year, with the number of business deals sealed during the past 3 days reaching 440 million dirhams. Over the years, Dubai Derma has firmly positioned itself as the leading global skin conference and exhibition in the Middle East, North Africa and the Indian subcontinent. With its rich scientific agenda, key trending topics and a list of world renowned speakers, Dubai Derma 2018 has attracted over 15,000 visitors and participants, while also featuring the participation of 540 companies from 95 countries.”

He added, “Dubai Derma owes its success to the continuous support of all its key partners and stakeholders in the region and abroad, in addition to the strong support offered by the Government of Dubai and Dubai Health Authority (DHA). We are confident that visitors and participants attending Dubai Derma enjoyed the highly interactive atmosphere offered during the conference and exhibition and also had the chance to experience the latest technologies used in the field of dermatology.”

On the 3rd and final day at Dubai Derma 2018, world renowned skin health experts and specialists from the UAE and abroad discussed a number of topics in skincare under many sessions including Hair, Immunology, Therapeutics, Cutaneous Manifestations in Systematic Disease, Treatment Challenges, Expert discussions on complicated cases, Cosmetic Dermatology, Innovations, Vitamin D Level in Acne Patients and its Association with Disease Severity among others.

While commenting on the optimum Vitamin D levels required in Acne patients and its impact on the severity of various skin diseases, expert skin specialists highlighted that although vitamin D is most well-known for its role in calcium absorption, it also affects skin conditions, including acne and psoriasis, both of which can be caused by an insufficient amount of vitamin D. According to the American Academy of Orthopedic Surgeons, AAOS, the daily recommended allowance of Vitamin D among most adults range from 600 International Units IUs, up to 4000 IUs to support bone health. Whereas hormonal imbalance and overall hygiene are primary causes of acne, AAOS suggest that a poor immune system due to lower amounts of vitamin D can sometimes aggravate acne while optimum level of sun exposure raises vitamin D levels, reduces the number of bacterial cells in our system and reduces acne levels.

Vitamin D deficiency is a major health issue around the world, with studies suggesting that it is associated with a 30 to 50 percent increase in the risk of contracting cancer while over 75 percent of people with various cancers were reported to have lower levels of Vitamin D and the lowest levels even witnessed advanced cancers. With a very large section of UAE’s population reported to be vitamin D deficient, efforts are ongoing in the UAE to adopt the appropriate national guidelines on the detection, prevention and treatment of Vitamin D deficiency while also ensuring that vitamin D screening is standardized in the country.

The annual Dubai World Dermatology and Laser Conference and Exhibition – Dubai Derma is organized by INDEX Conferences & Exhibitions - a member of INDEX Holding, in cooperation with the Pan Arab League of Dermatology, Arab Academy of Dermatology & Aesthetics (AADA) and GCC League of Dermatologists with the support of the Government of Dubai and Dubai Health Authority (DHA).

- End -

- ASIA TODAY News Global Distribution

INDEX Announces the Launch of Asia Derma in Singapore this December
Mar 21, 2018

United Arab Emirates, Dubai, 21 March 2018 --( ASIA TODAY )-- INDEX Conferences & Exhibitions, member of INDEX Holding, is proud to announce the launch of Asia Derma, the Asia-Pacific Dermatology and Aesthetic Conference & Exhibition. The event will be held from the 5th to the 7th December 2018 at SUNTEC Convention & Exhibition Centre in Singapore. Asia Derma is set to be an exclusive platform dedicated to dermatologists, skin specialists and industry leaders in Asia-Pacific region. This announcement came in a press conference that was held earlier today on the sidelines of the 18th Dubai Derma Conference & Exhibition.

Inspired by 18 successful editions of the famous Dubai Derma Conference & Exhibition, Asia Derma will be focusing on the Asia-Pacific markets. The 3-day scientific event is expected to witness the participation of more than 100 exhibitors and industry leaders and attract over 1,500 trade visitors and delegates.

Commenting on the launch, Eng. Anas Al Madani, Vice-Chairman and Group CEO of INDEX Holding said: “While the global dermatology market is projected to reach 33.7 billion dollars in 2022, latest estimates by GBI market research suggest that the ‘Asia-Pacific’ region is the fastest growing market for dermatology devices leaving North America and Europe behind. With the increasing prevalence of skin disorders, increasing awareness of aesthetic procedures, developing technologies and rising disposable income in emerging markets, the Asia Pacific region is today driving the industry’s quest for effective skincare solutions.” He added, “The ‘Asia Derma’ Conference and Exhibition has made its debut at the right opportune time in Singapore, which is the business and financial nerve centre of the Asia-Pacific region, and we hope visitors and participants attending this global international skincare event will take advantage of the highly interactive environment provided at the venue.”

On his part, Professor Goh Chee Leok, Chairman of Asia Derma 2018 Scientific Committee, Singapore, said: “The inaugural Asia-Derma Conference & Exhibition will be held in Singapore in December, this year. The organising committee has planned a comprehensive scientific programme that will provide an exceptional opportunity for practitioners to share their experience, improve their knowledge, and enhance their skills in dermatology and aesthetic medicine. The trade exhibition, running parallel to the conference, will also create an opportunity for the industry professionals to introduce the latest skincare technologies in medical care.”

From his side, Doctor Hasan Galadari, Co-Chairman of Asia Derma 2018 Scientific Committee, said: "Dermatology in Asia has always been a rich and robust specialty. What we promise in Singapore is a medium that will help showcase this, shed the spotlight on the specialty and the success of those who have practiced it. Information, knowledge and education will be key elements shared and the inaugural edition of Asia Derma will help do that."

Asia Derma 2018 Scientific Committee is composed of eminent regional and international dermatology experts and collaborates with regional dermatology and aesthetic societies. It is also supported by the Aesthetic Dermatology Educational Group-ADEG.


About INDEX Conferences & Exhibitions:

Established in 1991, INDEX Conferences & Exhibitions, is a leading national company specialized in events management. Over the years, INDEX Conferences and Exhibitions has organized a range of events in various fields that included Medical, Economic, Industrial, Academic, Trade, Investment, Business and many others.

Over the past 25 years, INDEX’s achievements have contributed to 25% of the UAE’s market share in the events industry, and attracted more than 1 million visitors from 133 countries to come to Dubai in order to participate, visit, and benefit from the events it organised.

For more information about Asia Derma, please contact:
For any media inquiries, please contact:

Suzan Mounzer
Public Relations & Social Media Manager
Email: | Direct: +97145208830 | Mob: +971569070443 | Tel: +97145208888 - Ext: 209 | Fax: +97143384193 | P.O. Box: 13636, Dubai - United Arab Emirates | Address: INDEX Holding Headquarters, Road D-62, Opposite to Nad Al Hamar, Dubai

Sophie Dudicourt
Business Development Director
Email: | Mobile: +971 50 107 5803 | Tel: +971 4 520 8888 - Ext: 661 | Fax: +971 4 338 4193 | P.O. Box: 13636, Dubai - United Arab Emirates | Address: INDEX Holding Headquarters, Road D-62, Opposite to Nad Al Hamar, Dubai

- ASIA TODAY News Global Distribution

Green Tea-Based Drug Carriers Improve Cancer Treatment
Mar 16, 2018

Singapore, March 15, 2018 - The Institute of Bioengineering and Nanotechnology (IBN) of A*STAR has reported superior results using new green tea-based nanocarriers to kill liver cancer cells, compared to existing drug delivery systems. IBN Team Leader and Principal Research Scientist, Dr Motoichi Kurisawa, and his group recently published their findings in the scientific journal Advanced Materials.

Researchers working on drug carrier technologies to improve cancer treatment face two key challenges. First, existing carriers used to transport drugs to tumor cells in the body can typically carry only about 10% of their weight in drugs. This means that more carriers are needed to deliver a specific amount of drugs, and patients would require more frequent injections or a larger dosage per treatment to kill cancer cells effectively.

Secondly, current carrier systems are unstable. As they move around in the body, they are easily diluted in the bloodstream or destabilized by plasma proteins. This leads to leakage of the drugs before the carrier reaches its intended target, thus harming healthy cells along the way to the tumor site. These shortcomings of current carrier systems result in less effective therapy and potential toxic side effects for the patients.

In 2014, IBN researchers led by Dr Kurisawa created self-assembling nanocarriers from epigallocatechin-3-O-gallate (EGCG), a known antioxidant found in green tea, and Herceptin, a breast cancer drug. Those nanocarriers could load and deliver more drugs to the cancer cells, and killed them more effectively than other formulations of the drug (Nature Nanotechnology, 2014). Now, the team has applied the same approach to make new nanocarriers from EGCG and Doxorubicin, which can carry up to 88% of their weight in drugs. Doxorubicin is used to treat a variety of different cancers, such as that of the breast, bladder and liver, as well as leukemia. IBN’s green tea-Doxorubicin nanocarriers were tested in a liver cancer mouse model and displayed superior tumor-killing performance and stability with minimal unwanted toxicity, when compared with two other clinical formulations of Doxorubicin.

“This study corroborates our earlier findings and demonstrates the versatility of our green tea-based carrier system. We are excited about the potential of using our technology as a universal vehicle for delivering other chemotherapeutics to treat different types of cancer,” said IBN Executive Director Professor Jackie Ying.

The uniqueness of IBN’s nanocarrier lies in the strong intermolecular interaction between the structurally similar EGCG and small molecule anti-cancer drugs. This interaction facilitates drug loading and also provides excellent thermodynamic and kinetic stability to the carrier.

According to Dr Kurisawa, “The unprecedented amount of drug loading in our new nanocarriers allows us to kill more liver cancer cells effectively. We are hopeful that our technology would lead to fewer side effects in patients.”

The researchers are now evaluating the loading of other types of drugs in the carrier.

1. K. Liang, J. E. Chung, S. J. Gao, N. Yongvongsoontorn and M. Kurisawa, “Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)-Green Tea Catechin Conjugate for Cancer Therapy,” Advanced Materials, (2018) 1706963.
2. J. E. Chung, S. Tan, S. J. Gao, N. Yongvongsoontorn, S. H. Kim, J. H. Lee, H. S. Choi, H. Yano, L. Zhuo, M. Kurisawa and J. Y. Ying, “Self-Assembled Micellar Nanocomplexes Comprising Green Tea Catechin Derivatives and Protein Drugs for Cancer Therapy,” Nature Nanotechnology, 9 (2014) 907-912.

Media Contacts:

Nidyah Sani
Phone: +65 6824 7005

Elena Tan
Phone: +65 6824 7032

- ASIA TODAY News Global Distribution

540 Companies, 265 Top-notch speakers, 164 Scientific Sessions, 72 Workshops & 70 Poster Presentations at Dubai Derma 2018
Mar 16, 2018

Dubai --( ASIA TODAY )-- United Arab Emirates, 16 March 2018: Under the patronage of His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of the Dubai Health Authority, the 18th edition of Dubai World Dermatology and Laser Conference and Exhibition – Dubai Derma, the largest event of its kind in the MENA region, dedicated to dermatology, skin care and laser, will be begin this Monday 19th of March 2018, at the Dubai International Convention & Exhibition Centre.

In its current edition, Dubai Derma 2018 is expected to attract over 15,000 visitors and participants, while also witnessing the participation of 540 companies from 95 countries. The 3-day conference and exhibition, occupying 11,500 square meters is set to play host to 265 expert speakers, specialists of skin health from the region and the world while also featuring 72 workshops, 164 scientific sessions and 70 poster presentations. In addition, delegates and participants attending the premier global skin conference will have the opportunity to gain 18 CME Credit Hours from the UAE University.

For the first time this year, Dubai Derma 2018 will jointly be held in conjunction with the 11th Asian Dermatological Congress by the Asian Dermatological Association while also hosting the first ever session of the American Academy of Dermatology in the Middle East, (AAD), which is the world’s largest dermatologic society representing 19,000 physicians.

Dubai Derma will also be hosting the presidents of the five biggest Dermatology Associations in the world to take part in the event including: the American Academy of Dermatology (AAD), the European Academy of Dermatology and Venereology (EADV), the Asian Dermatological Association (ADA), the Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) and the 24th World Congress of Dermatology (WCD).

Dr. Ibrahim Galadari, Professor of Dermatology at the UAE University, and Conference Chairman of Dubai Derma said: “I am delighted to announce that the 11th Asian Dermatological Congress by Asian Dermatological Association (ADA) will be held in conjunction with Dubai Derma 2018 on March 19-21 at the Dubai International Convention & Exhibition Center. Dubai Derma will bring together eminent speakers from the region and around the globe covering a wide spectrum of themes affecting the world of dermatology. The Dubai Derma scientific program features a four-day pre-conference course, conference program, workshops and live demonstrations exemplifying novel cosmetic and dermatological procedures.”

“In addition, the American Academy of Dermatology - AAD will have their own first session internationally and Dubai Derma fully appreciates the upmost support and collaboration with AAD. Dubai Derma provides all dermatology colleagues worldwide with a vibrant platform to update their knowledge, explore new advances in the dermatological and technological field, and foster closer ties.” He concluded

"The members and council of the Asian Dermatological Association are looking forward to participating in this 18th Dubai Derma 2018 Conference which is in collaboration with our very own 11th Asian Dermatological Congress (ADC). The last time the ADC was held in Dubai was 26 years ago. This joint event promises to be a world-class educational and multi-cultural highlight of our International Dermatologic Community. I invite all friends and colleagues to be a part of this most anticipated event of the year. " Dr. Steven Chow, President of the Asian Dermatological Association

From his side, Dr. Henry W.Lim, President American Academy of Dermatology “As the president of the American Academy of Dermatology, I am pleased that the AAD has established a collaboration with Dubai Derma 2018 by having an AAD session at the meeting. Having been a participant of Dubai Derma in the past, I am well aware that this is a well-organized, informative meeting. I am looking forward to participating at Dubai Derma 2018, and a fruitful and successful collaboration.”

In addition, Dubai Derma, this year, will dedicate 2 full days for Case Report Presentation and Competition, in order to encourage dermatology researches in the region and abroad, wherein dermatologists and resident doctors from different countries will be present to showcase their case reports. Moreover, a poster presentation competition will offer a unique opportunity for researchers in the UAE and abroad to present their work and illustrate their research methods and outcomes.

Running parallel to the conference, Dubai Derma Exhibition, aims to provide an ideal opportunity for exhibiting companies to network, partner and expand their businesses in the Skin Care, Aesthetic and Laser market among many other such fields. Furthermore, the exhibition will play host to a number of product launches and live demonstration of latest skincare solutions while also offering a highly interactive environment for visitors to experience the latest products and services in the skincare industry.

Prior to the main Dubai Derma Conference and Exhibition, the Pre-Conference Courses on Dermatology and Dermatopathology started today 16th of March, 2018 at the Dubai International Convention and Exhibition Centre, and will continue to the 19th of March, 2018. These courses will be focusing on various key trending topics in skincare including ‘Breakthrough in Vitiligo Managing Red Face, Introduction to Non-Invasive Technologies, Naked eye to Nucleotide Dermoscopy ASAP, Reflectance Confocal Microscopy, Difficult Cases for Discussion, OCT and other technologies, Biologics in Dermatology, Trichoscopy and Dermoscopy, Genetics in Dermatology, Cutaneous Surgery, Treatment Monitoring, Hair and Nails among others.

The annual Dubai World Dermatology and Laser Conference and Exhibition – Dubai Derma, is organized by INDEX Conferences & Exhibitions - a member of INDEX Holding, in cooperation with the Pan Arab League of Dermatology, Arab Academy of Dermatology & Aesthetics (AADA) and GCC League of Dermatologists with the support of the Government of Dubai and Dubai Health Authority (DHA).

- End -

- ASIA TODAY News Global Distribution

Kidney Failure – Women more at risk?
Mar 15, 2018

Malaysia, March 2018 --( ASIA TODAY )-- When it comes to Chronic Kidney Disease (CKD), women may be more likely to develop the illness than men. According to studies by the Institute for Health Metrics and Evaluation, the average prevalence of CKD in women is 14% as opposed to 12% in men.

Interestingly, researchers also found that men were likely to go on dialysis earlier in the course of their illness compared to women, for reasons that aren’t fully known.

Prof. Dr. Goh Bak Leong Head and Senior consultant nephrologist in Serdang Hospital, who is also the president of the Malaysian Society of Nephrology, says that there could be a variety of reasons for this including uneven access to healthcare for women in some countries.

“While the reason is unclear why this illness affects men and women differently, it is something that has consistently been observed across the world, in both the developed and developing countries,” says Prof Goh.

Such gaps in treatment and care are part of what organisations like the National Kidney Foundation (NKF) hope to address as part of its ongoing mission.

57-year-old Puan Zaedah binti Jali has been undergoing dialysis treatments at NKF for the past 20 years now.

Having been diagnosed with two failed kidneys at just 37, she was thus forced to turn to NKF after being rejected as a potential candidate for a kidney transplant. The former factory worker now spends her days resting at home and thanking the Almighty for a fairly blissful life, as her children are all grown up and independent.

Puan Melini binti Ismail’s story is slightly different. Having completed her professional ACCA in the UK, Malini landed a job in a German Firm and later TV3 as an accountant. Then in 2012, a blood test revealed that her kidneys were not functioning the way they should. By then she already knew she had diabetes and hypertension but was unable to proceed with the dialysis due to her work commitments.

Despite being someone who loves to travel and enjoys food, Melini has been forced to cut back on these activities since being diagnosed with CKD and commencing dialysis treatments with NKF.

“I once had a scare when I indulged in some nasi dagang and was admitted to the hospital for two days! I have since started making more effort to cook and eat healthier foods,” shared Melini.

“The only issue I face is that when I travel I need to find areas which have dialysis centres and book my sessions in advance, and this can be cumbersome especially overseas. So I have cut back on traveling tremendously, with the exception of traveling back to my hometown in Kota Bahru, which has an NKF branch,” she said.

Former assistant nurse, Puan Zaliha bt. Sis, who has been undergoing dialysis since 1978 is grateful for the assistance provided by NKF to enable her to enjoy a better quality of life since her diagnosis.

“I had the opportunity to receive a kidney from my mum in 1979, but after the surgery my body rejected it. So I went back to dialysis and am not looking for another donor kidney,” she said, adding that her family and her husband’s family have always taken good care of her and supported her throughout her treatments.

Chuy Oi Lan, 63 years old, who is formerly a factory worker was diagnosed with kidney failure in year 1993 and have been undergoing dialysis treatment with NKF since 2012. She has also received funding from the Social Security Organisation (SOCSO) for her dialysis cost at the hospital.

Aside from being an end stage renal disease (ESRD) patient, Chuy Oi Lancis also a survivor of breast cancer. “You should never give hope no matter how hard life is, because your family and friends will always have your back,” she said.

Patients like 40-year-old Shela Devi continue to benefit from haemodialysis treatments at NKF, as her family is not well-off. Although she has registered as a recipient for a donor kidney she has not yet heard any good news. With no transplant in sight, she is thankful to NKF for prolonging her health and life so she can eventually see all her children grow up and have their own families.

“I am glad that I am receiving the best possible care from NKF, whose staff members treat all patients with professionalism and take the trouble to lend their ears for us to confide in. Many of our concerns have been eased, and I have also benefitted from a friendly and family-like atmosphere at the centre,” said Shela.

These women are proof that while CKD is a debilitating disease and dialysis treatments are physically and financially draining, a decent quality of life is still possible with the right treatment.

According to Prof. Goh, there are a number of steps that can be taken to prevent the advancement or onset of kidney disease. These include consistent screening for kidney disease and adequately controlling blood pressure and blood sugar.

“Perhaps women need to take better care of themselves and be more proactive in seeking out treatments once they are diagnosed with the illness. I think often times women may tend to delay their treatment due to commitments to the family and their role as caregiver, or fear that their lifestyle could be affected as a result of the treatment. But this is far from the truth. If anything, the countless women who are being treated at NKF prove that it is possible to lead a good life and enjoy better quality of life once you seek the relevant treatment,” advised Prof. Goh in conjunction with World Kidney Day.

Sidebar: Risk factors for age-related kidney disease

Some conditions that affect the kidneys are more common as people get older. You are more at risk of developing kidney disease if you:

• are over 60 years of age
• have diabetes
• are obese
• have high blood pressure
• have established heart problems (heart failure or past heart attack) or have had a stroke
• are a smoker
• have a family history of kidney failure
• have a history of acute kidney injury

Keeping your kidneys healthy

There are a number of things you can do to keep your kidneys healthy, including:

• If you have diabetes, make sure that your blood sugar control is excellent. Follow your doctor’s advice about insulin injections, medicines, diet, physical activity and monitoring your blood sugar.
• Control high blood pressure. Have your blood pressure checked regularly. Drugs used to lower blood pressure (anti-hypertensive drugs), such as ACE inhibitors or angiotensin blockers, can slow the development of kidney disease.
• If you have one of the risk factors for kidney disease, have a kidney health check (blood test, urine test and blood pressure check) at least every year (more frequent if you have diabetes or high blood pressure).
• Treat urinary tract infections immediately.
• Control blood cholesterol levels with diet and medications if necessary.
• Drink adequate water and choose foods that are low in sugar, fat and salt, but high in fibre. Stick to moderate serving sizes.
• Do not smoke.
• Drink alcohol in moderation.
• Stay at a healthy weight for your height and age.
• Try to exercise moderately for at least 30 minutes a day.

For more information on these and future NKF activities or to donate towards the organisation’s efforts, please visit or call 03-7954 9048.


National Kidney Foundation of Malaysia
The National Kidney Foundation (NKF) Malaysia is a non-profit charitable organization dedicated to helping Malaysians suffering from end stage kidney failure who lack access to or cannot afford dialysis treatment. NKF currently has over 1,500 dialysis patients receiving subsidized dialysis treatment in over 26 dialysis centers nationwide.

Photo by on Unsplash

- ASIA TODAY News Global Distribution launches a free, Laboratory Information Management System (LIMS), FreeLIMS, for every laboratory
Mar 15, 2018

San Francisco CA – March 15, 2018, is pleased to announce the launch of its secure, LIMS, FreeLIMS, available at no charge, for every research organization wanting to manage data seamlessly, automate workflows, and streamline laboratory operations. FreeLIMS enables laboratories to replace spreadsheets and paper notebooks with a LIMS which does not need any computer hardware. Laboratories are therefore, able to accelerate their efficiency and reduce operational costs when there is a budgetary constraint and yet a need to automate. FreeLIMS is specifically designed for researchers, technicians and laboratory managers across all industries, including biobanks, clinical research, testing, food and beverage, cannabis, oil and gas, petrochemical, water, agricultural and environmental laboratories.

Here is a list of some of the key functionality of FreeLIMS:

Sample Management: The Sample module helps in managing the entire life cycle of a sample, right from when a sample enters a laboratory to the sample's disposal.

Patient Management: The Subject module plays a pivotal role in managing and storing patient data, including demographics and patients' medical history. Additionally, it can generate comprehensive reports in the desired format in a few clicks, masking necessary fields as per HIPAA compliance.

Storage Management: The Storage module enables seamless and quick tracking of storage locations of all samples in a freezer or refrigerator.

Test Management: The Test module enables testing laboratories manage and track tests, both quantitative and qualitative, for multiple analytes. Additionally, it facilitates automated report generation of test results and maintaining Chain of Custody (CoC).

Meet Regulatory Guidelines: FreeLIMS helps laboratories follow regulatory guidelines such as HIPAA, 21 CFR Part 11 and help laboratories meet ISO 17025 compliance. The audit trail functionality records all laboratory activities performed by all users automatically along with date and time stamp.

To get a free license, sign-up on and start using a LIMS today.

About FreeLIMS

FreeLIMS is an energetic team producing cloud-based Laboratory Information Management System (LIMS) to facilitate laboratories seamlessly manage their data and automate their laboratory workflows.

Mrinal Kanti Chatterjee
2450 Market Street
San Francisco CA 94114-4226

- ASIA TODAY News Global Distribution

Thailand motivates TB patients to receive treatment
Mar 13, 2018

Patient-centered approach overcomes resistance

February 2018 — Sirichai* is a construction worker who lives with his wife in Thailand’s Rayong province. In 2013, he was diagnosed with tuberculosis (TB) and has undergone multiple courses of treatment since then. At the age of 50, he learned that he had severely drug-resistant tuberculosis, and doctors recommended an operation to remove part of his lung.

That same day, Sirichai left the hospital with no plans to return or to have the procedure.

Rather than giving up on Sirichai, his health care team visited him at home to use their proactive approach and discuss his concerns. Sirichai worried about the long trip to the hospital for the lung surgery, and he wondered about who would take care of him afterwards.

“So, when will I be picked up tomorrow? What preparations do I have to do?” asked Sirichai. “I want my son to come with me.”

The team explained the support they could offer, including transportation to the hospital, care during his in-patient stay, and care after he returned home. With his concerns addressed, Sirichai decided to proceed with the operation.

“We gave him time to think and reflect, and the right to make the decision by himself. We only provided enough information so he could decide,” said Preeyapat Intrasub, provincial TB coordinator of the Rayong Provincial Health Office.

Sirichai continues his medicinal treatment and has been responding well. He returned to his construction job, and his health care team is confident that he will successfully complete treatment.

This is one example of the power of interviewing called Motiv8, which inspires patients to change their behavior based on internal motivation rather than external directive.

USAID’s Control and Prevention of Tuberculosis (CAP-TB) project has trained 26 health care providers in Thailand to use the motivational interviewing technique. Since 2015, these providers have been using Motiv8 to promote treatment adherence among TB and drug-resistant TB patients, and the novel approach is spreading in Rayong province.

Motivational interviewing challenges the typical patient-provider relationship where patients are simply expected to comply with providers’ recommendations. With this new approach, the patient and provider are partners in the decision-making process. When TB patients are engaged in this way, those who are ambivalent or resistant to treatment move toward getting the care they need and are more likely to be cured.

“I'm accepted by the patient and they open up to me more,” said a health care provider in Rayong following the Motiv8 training. “Before we knew Motiv8, we only gave information that we want to give to the patient. We rarely listened to the knowledge that they already had, how they think and feel, or what problems they faced.”

Proven effectiveness has led to Motiv8’s use with HIV and TB-HIV coinfected patients, both with and without USAID support. Given its success, continued scale-up of this approach could lead to better treatment adherence and improved outcomes in Asia and beyond.

Motiv8 is only one part of the broader USAID CAP-TB patient-centered approach being implemented in countries throughout Asia. The project, which runs from October 2011 through October 2018, has introduced successful patient-centered treatment programs for multidrug-resistant tuberculosis patients in China, Myanmar and Thailand. Tailored for each location, the project delivers consistently higher patient adherence and treatment success rates by focusing on the patient’s requirements, not just the challenging clinical regimens.


- ASIA TODAY News Global Distribution

Urgency in Raising Awareness of Kidney Disease
Mar 13, 2018

Kuala Lumpur, 8 March 2018 --( ASIA TODAY )-- In conjunction of World Kidney Day (WKD) 2018, National Kidney Foundation of Malaysia’s (NKF) Open Day took place today at the NKF – BERJAYA Resource Centre.

The day’s programme kicked off with a Bollywood Fitness Dance instructed by Mr Kirenjit Singh, the Bhangra Dance Master who was formerly a Fitness Manager for Celebrity Fitness. Free health screening was provided for public to keep track of their blood pressure, blood glucose, blood cholesterol level with counselling given by NKF’s health professionals. An organ donation booth was set up to encourage the public to pledge to donate their organs, which will go a long way in lending a new lease of life for people in dire need for organ transplants, including kidney transplants.
“In Malaysia, there is an increase of 6,000 new cases of patients who are diagnosed with kidney failure every year. This clearly indicates that there is an urgent need to increase public awareness on personal health, especially on diseases related to end stage renal disease (ESRD),” said Chua Hong Wee, CEO of NKF.

“Celebrated globally on the second Thursday in March, this year’s World Kidney Day coincides with International Women’s Day. As such, we would like to raise awareness of preventive measures in avoiding kidney disease, especially in women. We also added the Bollywood Fitness Dance as a new activity this year. Jointly organised by the Ministry of Health, Malaysian Society of Nephrology and National Kidney Foundation, this initiative will be held in various cities throughout Malaysia, including Johor, Seberang Prai, Sungai Petani and Alor Setar,” he added.

A health talk on the importance of annual medical check-up was conducted by Mr Nizam bin Yusof, Consultancy Manager of Medi Diastika Sdn Bhd to encourage members of public to take charge of their own health, as determining of bodily functions can help to identify any abnormalities or disease before they can worsen, display symptoms, and pose a significant risk.

With the theme of WKD being ‘Include, Value, Empower’ this year, Dr Nor Fadhlina Binti Zakaria from Faculty of Medicine and Health Sciences, University Putra Malaysia has shared the importance of women’s health and specifically their kidney health during the health talk on ‘Supplements, Women, and Kidneys Health’.

For more information on these and future NKF activities or to donate towards the organisation’s efforts, please visit or call 03-7954 9048.


National Kidney Foundation of Malaysia
The National Kidney Foundation (NKF) Malaysia is a non-profit charitable organization dedicated to helping Malaysians suffering from end stage kidney failure who lack access to or cannot afford dialysis treatment. NKF currently has over 1,500 dialysis patients receiving subsidized dialysis treatment in over 26 dialysis centers nationwide.

- ASIA TODAY News Global Distribution

Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Stroke Recovery
Mar 04, 2018

SINGAPORE, March 5, 2018 /PRNewswire/ -- Moleac, a biopharmaceutical company focused on research and development of new medicines for central nervous system (CNS) diseases and injuries, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational new drug (IND) application for a Phase 1 study of MLC1501, as first step of a clinical programme in post-stroke recovery treatment. Approval of this IND enables Moleac to initiate a safety study of MLC1501 in normal subjects as part of the overall clinical development plan for demonstrating that MLC1501 improves functional independence and recovery of motor, speech, cognition and other neurological dysfunctions in post-acute ischemic stroke (AIS) survivors having not recovered after acute treatments (thrombolysis, thrombectomy) or having not received them. Beyond the acute phase, there are no available treatments, other than rehabilitation measures, to relieve the disabilities suffered by stroke survivors. Proving clinical safety and efficacy of MLC1501 on long-term functional and neurological recovery in patients suffering from AIS will fill a therapeutic gap and help reduce the overall burden of stroke.

"This is a clear milestone for Moleac to commence development of MLC1501 an agent that has proven successful in Asia for use in the USA as a new treatment for post-stroke recovery, an area where we need more agents to reduce the devastating burden of stroke for patients and their families," said professor Lou Caplan of Beth Israel Deaconess Medical Center and Harvard University. "We already have learned much about the properties of the parent compound, NeuroAiD. This information will guide the clinical development of MLC 1501, and trials of its use in the USA." Prof Caplan added.

David Picard, CEO of Moleac, added, "The US FDA's clearance of this IND is validating our collaborative and determined approach to move into registration trials for post-stroke recovery. We are confident and eager that this Phase I study will confirm the safety of MLC1501 for starting as early as possible Phase II with international stroke centers and patients. We are grateful to all our colleagues, our partners in academia and our corporate partners without whom this step forward would not have been possible."

About Stroke

Stroke is considered among the world's most debilitating diseases with high mortality rate and afflicts over 17 million people worldwide each year, of which more than 80% of cases are ischemic stroke. Stroke not only endangers the lives of victims but also burdens the families of the stroke survivors with significant caretaking and financial expenses. Despite the use of revascularization treatments in AIS, a huge number of stroke survivors will suffer from disabilities causing a substantial impact on their day-to-day life and functioning, and a heavy financial burden on society.

About MLC 1501

MLC1501 is a further developed formulation consisting of four of the original nine herbs that are present in two parent formulations, MLC601 and MLC901 (NeuroAiD™). Pharmacological studies have demonstrated equivalent neuroprotective and neurorestorative properties of MLC1501 in nonclinical animal and cellular models of focal ischemia. Clinical trials of MLC601/MLC901 and systematic reviews of those trials showed benefit in improving functional and neurological recovery, in patients having functional impairment after an acute ischemic stroke.

About Moleac

Moleac is a biopharmaceutical company dedicated in finding, developing and commercializing worldwide new medicines for the unmet medical needs of patients suffering of central nervous system (CNS) diseases and injuries, such as stroke, dementia and traumatic brain injuries. To address therapeutic gaps, Moleac has pioneered a new drug development approach, looking at sources of innovation from Natural Medicines, hence shortening considerably drug development cycle time and investment to bring medicine to sufferers' unaddressed needs. Moleac's neurorestorative natural formulation NeuroAiD™ reaches patients in more than 30 countries where it is regulated.


Clément Dif, Business Development & Marketing Department
Phone: +65-62113710

Source: Moleac Pte Ltd

- ASIA TODAY News Global Distribution

Hearing loss linked to dementia
Mar 01, 2018

The study discovered that older people aged 55 and above with hearing loss are 2.3 times more likely to develop dementia

A local study on Singaporeans has revealed that people aged 55 and above with hearing loss are more likely to develop dementia. As more than 60 per cent of Singaporeans aged above 60 years old experience varying forms of hearing loss, the findings could prove to be significant; opening the possibility that early diagnosis and intervention for hearing loss could potentially delay dementia and cognitive decline.

The study, published in 2017, was conducted through the analysis of data from the Singapore Longitudinal Ageing Study, a long-term, population-based research, led by NUS Yong Loo Lin School of Medicine (NUS Medicine) Associate Professor Ng Tze Pin, which investigates the ageing and health of community-living elderly in Singapore.

A total of 1,515 Singaporeans aged 55 and above were involved in the research study linking hearing and dementia. The participants had normal memory and thinking skills at the start of the study and were observed through two rounds of follow-up at regular intervals over a period of about three years. Using cognitive and clinical assessments, it was found that cognitively normal participants with hearing loss were about 2.3 times more likely to develop mild cognitive impairment or dementia.

The results are consistent with findings conducted in Western populations — US, UK and Australia — which adds weight to the potential link between hearing loss and cognitive decline and dementia.

It is indeed feasible now for us in Singapore to consider screening for risk of dementia, and to design appropriate community-based multidomain lifestyle interventional programmes, to help older Singaporeans ‘age without dementia’.
— Assoc Prof Ng Tze Pin, NUS Medicine

Assoc Prof Ng said that risk and protective factors for dementia, including hearing loss, are modifiable with suitable lifestyle changes. “It is indeed feasible now for us in Singapore to consider screening for risk of dementia, and to design appropriate community-based multidomain lifestyle interventional programmes, to help older Singaporeans ‘age without dementia’,” he said.

While there is not yet enough evidence to show how the link between hearing loss and dementia occurs, Dr Rebecca Heywood of Ng Teng Fong General Hospital and Principal Otolaryngology researcher of the published study offered some theories. “Those with hearing loss need more effort to hear a degraded sound, so less brain resources are available for thinking and memory. Hearing loss results in less auditory stimulation and as a result the hearing areas in the brain, which are also involved in memory, become underused and decline in function. It is also possible that hearing loss may give rise to social isolation, which is itself a risk factor for cognitive decline.”

Dr Heywood added that hearing loss is easily diagnosed and treated and should not be seen as an inevitable part of ageing, urging sufferers to seek help.

Assoc Prof Ng and Dr Heywood plan to conduct a follow-up intervention study to examine how the use of hearing aids can help to reduce the rate of cognitive decline and delay the onset of dementia in older adults with hearing loss.

SOURCE / National University of Singapore

- ASIA TODAY News Global Distribution